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Abstract 
Background: The Development and Well-Being Assessment (DAWBA) has been used in various 
epidemiological studies whereas the clinical value of the instrument needs support from further 
studies. In particular, it is important to document how the use of the DAWBA influences clinical 
decision making. Methods: The present study employed the DAWBA in a consecutive series of 
270 new referrals to a large public child and adolescent psychiatric service in Zurich, Switzerland. 
ICD-10 based diagnoses were obtained from clinicians for all patients and reliability of DAWBA 
expert raters was calculated. DAWBA diagnoses were randomly disclosed (N=144) or not 
disclosed (N=126) before clinical decision making. Results: The reliability of DAWBA expert 
diagnoses was very satisfactory and the agreement under the disclosed vs. the non-disclosed 
condition amounted to 77% vs. 68% for internalizing disorders and to 63% vs. 71% for externalizing 
disorders. The increment in agreement due to disclosure of the DAWBA diagnosis was significant 
for internalizing disorders. Access to DAWBA information was more likely to prompt clinicians to 
add an extra diagnosis. Professional background and degree of clinical experience did not affect 
diagnostic agreement. Conclusions: Overall, diagnostic agreements between DAWBA expert 
diagnoses and clinical diagnoses were in the fair to moderate range and comparable to previous 
studies with other structured diagnostic interviews. The inclusion of the DAWBA into the clinical 
assessment process had an impact on diagnostic decision making regarding internalizing disorders 
but not regarding externalizing disorders.  
Keywords: diagnosis, standardized diagnostic interview, clinical judgment, child and adolescent 
mental health  
 
Trial register name: The utility of standardized pre-clinical assessment based on the Development And Well-
Being Assessment (DAWBA) in a child and adolescent mental health service, registration identification 
number: ISRCTN19935149, register-url: http://www.controlled-trials.com/ISRCTN19935149/DAWBA 
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Introduction 
Research has shown several information-gathering biases of clinicians when using unstructured 
interviews, such as deciding on the diagnosis before collecting all relevant data, seeking 
information to confirm a previous diagnosis, ignoring conflicting information, combining information 
in ways that do not match diagnostic criteria, and various assumptions based on gender, ethnicity, 
and psychosocial backgrounds [8, 9]. Accordingly, the agreement between standardized diagnostic 
interviews (SDI) and clinical diagnoses was rather low in a recent meta-analysis by Rettew and 
colleagues [26] with Cohen’s kappa for internalizing disorders amounting to 0.28 and for 
externalizing disorders to 0.29. There is some evidence that treatment outcomes regarding therapy 
engagement and internalizing disorders were significantly worse when clinical diagnosis did not 
agree with diagnosis based on SDI [17]. However, others studies found diagnoses from SDI to be 
of limited use. For example, Duffy [5] found that SDI based on DSM-IV or ICD-10 may lead to an 
increase of false positive cases of bipolar disorders as a result of not considering psychiatric 
history. Although the reliability and validity of diagnoses based on unstructured interviews were 
poorer compared to SDI-based diagnoses [3, 18, 19], the clinical utility of SDI still remains a matter 
of concern. It is worth noting that SDI-based diagnoses underlie most clinical trials, so the evidence 
base for what does and does not work in child and adolescent psychiatry is particularly relevant to 
individuals with SDI-based diagnoses.  
 
Many clinicians do not recognize the benefit of SDI over clinical judgments and are concerned 
about the practicality of SDI [16] or that SDI may damage the therapeutic alliance [21]. 
Furthermore, professions other than psychologists (i.e. psychiatrists, social workers) have more 
negative attitudes regarding the use of SDI in clinical practice [16]. To date, the effects of SDI on 
clinicians’ diagnostic decision making have not been systematically studied. Thus, it is unclear how 
far SDI can actually improve assessment and subsequent treatment in everyday practice. 
  
The Development and Well-Being Assessment (DAWBA) [13] is a potentially promising SDI for use 
in routine clinical work for several reasons. Firstly, its mixture of structured and open-ended 
questions means that clinicians can review descriptions of problems in the respondent’s own 
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words. Secondly, the DAWBA can be administered via a secure internet connection, with 
advantages for respondents, clinicians and service managers. Online completion is often 
convenient for respondents. In addition, the DAWBA covers all major diagnoses, including co-
morbidities which might be missed in clinical interviewing due to focusing on the referral complaints 
only. Finally, DAWBA items refer to ICD-10 and DSM-IV diagnostic criteria and inbuilt diagnostic 
algorithms provide useful guides to the likelihood of different diagnoses. Despite these possible 
advantages, the effects of the DAWBA and other SDI on clinicians’ diagnostic decision making 
have not been systematically addressed.  
 
The initial validation of the DAWBA involved a study of both a community and a clinic sample [13] 
and the instrument has been used ever since in various epidemiological studies in Britain [7], Brazil 
[6], Bangladesh [24], Norway [15] and Russia [14]. In addition, two clinical studies based on the 
DAWBA [1, 24] found higher agreements between DAWBA expert-rated diagnoses and clinicians’ 
diagnoses (Cohen kappa of 0.63 to 0.94) than expected from previous research based on other 
SDI [26]. However, both of these studies were performed in low income countries and were based 
only on small teams of clinicians. To date, there are no published studies of the agreement 
between DAWBA and clinical diagnoses in large samples drawn from sizeable psychiatric clinic in 
high income countries. 
 
The present study addressed the issue of how DAWBA information influences routine clinical 
practice. DAWBA diagnoses generated by expert raters were compared with independent 
diagnoses generated by clinicians in a consecutive series of new referrals of children and 
adolescents to a large public service. To test whether or not the disclosure of DAWBA diagnoses 
has an effect on clinical decision making, the DAWBA diagnoses were randomly either disclosed or 
not disclosed to clinicians prior to their routine assessment. It was assumed that the disclosure of 
DAWBA information before final decision making increases the total diagnostic agreement as well 
as the positive agreements regarding internalizing and externalizing disorders. This part of the 
study was modeled after the design of the study by Ford et al. (submitted) so that the findings may 
serve as cross-validation. 
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Given the heterogeneity in clinical expertise within a large clinical service and in line with previous 
findings [27], the present study analyzed whether or not the degree of clinical experience (more or 
less than 4 years clinical practice) and professional background (psychiatrists vs. psychologists) 
affected the agreement of DAWBA and clinical diagnoses with and without previous disclosure of 
DAWBA.  
Method 
Sample 
A total of 875 children and adolescents older than 5 years admitted to the outpatient department of 
the Child and Adolescent Psychiatric Service, University of Zurich, Switzerland between September 
2007 and June 2009 were eligible for the present study (see Figure 1). After exclusion of 521 
subjects due to a lack of parent motivation or insufficient knowledge of the German language, 
ratings were available for 354 children and adolescents. Furthermore, data on patients with 
adjustment disorders as primary diagnosis had to be excluded from analyses because there is no 
equivalent in the DAWBA. Lack of parent information led to further exclusions. The final sample 
consisted of a total of 270 children and adolescents aged 5 to 18 years (mean 10.46 years, 
SD=3.56 years) including 184 (68.1%) boys and 86 (31.9%) girls. The sample where DAWBA 
information was not disclosed (n=126) consisted of 90 boys (71.4%) and 36 girls (28.6%) with a 
mean age of 10.2 years (SD=3.5 years). In contrast, the sample where DAWBA was disclosed 
(n=144) consisted of 94 boys (65.3%) and 50 girls (34.7%) with a mean age of 10.7 years (SD=3.6 
years). The two samples did not differ regarding to sex (chi2=1.17, df=1, p>0.05) and age (t=0.97, 
df=268, p>0.05) of the participants. In addition to a parent DAWBA in all instances, there was a 
youth self-report DAWBA in 79 instances and a teacher DAWBA in 117 instances. Informed 
consent for participation in the study was given by all participating parents and teachers. In 
addition, the study was approved by the local ethics committee of the Canton of Zurich and is 
registered as a randomized clinical trial (ISRCTN 19935149).  
 
Measures 
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Development and Well-Being Assessment (DAWBA) 
The Development and Well-Being Assessment (DAWBA) interview consists of questionnaires, 
interviews, and rating approaches designed to generate ICD-10 and DSM-IV diagnoses on children 
aged 5 to 16 years [13]. There are parallel interviews for parents and 11-16 year olds; and there is 
a brief questionnaire for teachers. Respondents initially complete the Strength and Difficulties 
Questionnaire [11, 12] before moving on to detailed interview sections covering a wide range of 
specific diagnoses. The DAWBA can be completed online via the internet. The computer program 
of the DAWBA brings together the different sorts of information and proposes likely diagnoses [10]. 
Experienced clinical raters have to decide then whether to accept or overturn the diagnoses in the 
light of all the data, including transcripts. In a recent comparison between the DAWBA and two 
other SDIs, i.e., the Diagnostic Interview Schedule for Children (DISC) and the Child and 
Adolescent Psychiatric Assessment (CAPA), the DAWBA was a relatively conservative measure, 
generating fewer diagnoses than the other two measures [2]. The German version of the DAWBA 
was used in the present study. Further information on the DAWBA including translations in many 
languages and online demonstrations of the clinical rating procedure are available via 
www.dawba.info.  
 
Procedure 
Respondents with internet access completed the online interview at a time and place of their 
choosing. Respondents without internet access were able to complete the online interview 
immediately prior to their clinic appointment using a dedicated computer in the clinic. Parents had 
to have a sufficient knowledge of the German language to understand the DAWBA. After 
completion of the interview by the parents (and by youth or teachers in some instances), the three 
expert raters (CK, MA, CWM; all senior board-certified clinicians) generated diagnostic ratings on 
the basis of the DAWBA information, blind to information independently collected by the clinic. All 
three raters were initially trained in DAWBA rating by the author of the measure (RG). 
Subsequently, the raters met regularly to discuss difficult cases in order to maintain consistency 
between raters. Random assignment for the disclosure or non-disclosure condition of the study 
was made by coin toss of the DAWBA raters after their diagnostic rating. There were no additional 
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restrictions for the randomization process. In case of disclosure, the corresponding clinicians 
received all available DAWBA information including expert rated diagnoses, SDQ results, and all 
information from parents, youths and teachers within 4 weeks of the DAWBA being filled out. In 
case of non-disclosure, clinicians were blind to DAWBA information until the assessment was 
finished. There were no adverse events or side effects in each group to report. 
 
The clinical diagnoses were based on ICD-10 and came from a large group of clinicians (N=65), 
comprising 23 child and adolescent psychiatrists and 42 clinical psychologists, collaborating in 
teams guided by a senior board-certified child psychiatrist. A total of 30 (46.2%) of the clinicians 
had more than 4 years of clinical expertise. To maintain diagnostic standards, junior clinicians were 
usually closely supervised by a senior team member. 
 
Statistical analyses    
Before entering into the main analyses, inter-observer reliability of the three DAWBA expert raters 
with an experienced DAWBA rater (AS) was tested by calculation of Cohen´s kappa coefficients. 
The main study consisted of various comparisons of rates of diagnoses. First, the distributions of 
diagnoses made by DAWBA experts and independent diagnoses in clinicians were compared 
using McNemar Chi-Square or binomial tests in the sample without DAWBA disclosure (i.e. where 
the two diagnoses were independent). Second, the overlap of DAWBA- and clinician-generated 
diagnoses was examined separately for those with and without disclosure of DAWBA ratings to 
clinicians; indices of agreement included the total and the positive agreements as well as the kappa 
coefficients. Third, the total and the positive agreements between the two conditions (disclosure, 
non-disclosure) were compared using Pearsons´s Chi-square statistics for any, internalizing, 
externalizing, and other disorders. Fourth, more vs. less experienced clinicians and psychiatrists 
vs. psychologists were compared regarding the total agreements of internalizing and externalizing 
disorders using Pearsons´s Chi-square statistics. To avoid alpha-error accumulation by multiple 
comparisons of diagnoses, the Benjamini-Hochberg method was used for adjusting the significance 
level of 0.05 [4].  
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Results 
Reliability of DAWBA expert diagnoses 
A random series of 60 DAWBA expert ratings were blindly re-rated by a senior rater who had been 
using the DAWBA before and had been involved in various studies of it. Kappa coefficients were 
0.83 (95%CI = 0.68-0.97) for any disorder, 0.84 (95%CI = 0.69-0.99) for any internalizing disorder, 
0.89 (95%CI = 0.77-1.00) for externalizing disorder, and 0.79 (95%CI = 0.39-1.00) for any other 
disorder. According to Landis and Koch [20] all coefficients have to be regarded as almost perfect. 
 
Frequencies of DAWBA expert diagnoses and diagnoses from clinician 
Among the 381 DAWBA expert-rated diagnoses and the 277 diagnoses given by clinicians to the 
present sample, 161 (42.3%) and 58 (20.9%) were rated as “unsure”, respectively. For the 
following analyses “unsure” diagnoses were scored as present. However, it has to be noticed that 
significantly more DAWBA expert diagnosis were rated as unsure compared to diagnoses from 
clinicians (m=0.59, SD=0.71 vs. m=0.21, SD=0.47, t=7.59, p<0.001).  
 
Table 1 shows the frequency with which different psychiatric diagnoses were made by DAWBA 
expert raters and by clinicians (including only those clinician ratings made blind to DAWBA 
information). The percentages did not sum to 100% because some children and adolescents had 
more than one diagnosis. According to the DAWBA expert ratings, 98 (77.8%) of the children and 
adolescents had at least one ICD-10 psychiatric disorder. Similarly, 97 (77.0%) of the children and 
adolescents were considered to have at least one ICD-10 diagnosis by the corresponding clinicians 
after full psychiatric assessment. The total number of disorders did not differ significantly. However, 
DAWBA expert raters more frequently diagnosed multiple disorders, whereas clinicians more 
frequently diagnosed a single disorder only. Furthermore, significantly more diagnoses were given 
by DAWBA expert raters for internalizing disorders, in particular for specific phobias and affective 
disorders. Although DAWBA raters and clinicians did not differ significantly in the number of 
externalizing disorders, ODD as a specific externalizing disorder was diagnosed significantly more 
frequently by DAWBA expert raters. In contrast, clinicians identified significantly more frequently 
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“other non specified diagnoses”. Further analysis of these 29 cases of “other non specified 
diagnoses” showed that clinicians most frequently diagnosed “other behavioural and emotional 
disorders with onset in childhood and adolescence” (10 cases, 34.5%) and enuresis (8 cases, 
27.6%). Enuresis is not covered by the DAWBA. 
Agreement of DAWBA expert diagnoses and clinical diagnoses with and without previous 
DAWBA disclosure 
The left column of Table 2 shows the agreement of independent diagnoses based on DAWBA 
experts vs. clinicians. Total agreement amounted to 78% (kappa=0.30) for any diagnosis, between 
67% and 83% for diagnostic categories (kappa=0.22-0.38), and between 74% and 99% for specific 
diagnoses (kappa=0.15-0.66). In the left column, agreements are shown for the sample with 
DAWBA information disclosed before clinical decision making. In this instance, total agreement 
amounted to 76% (kappa=0.15) for any diagnosis, between 63% and 87% for diagnostic categories 
(kappa=0.25-0.46), and between 73% and 100% for specific diagnoses (kappa=0.24-1.00). Under 
this condition, total agreement for internalizing disorders was higher when the DAWBA diagnoses 
was disclosed to clinicians before final decision making (chi2=3.13 df=1, p<0.05). By contrast, 
disclosure did not significantly influence the rate at which clinicians rated any diagnosis (chi2=0.36, 
df=1, p>0.05), externalizing disorders (chi2=1.99, df=1, p>0.05), or other disorders (chi2=0.00, df=1, 
p>0.05). In addition, there were no significant differences between the two conditions for positive 
agreements between DAWBA and Clinicians diagnoses regarding any diagnosis (chi2=1.30, df=1, 
p>0.05), internalizing disorders (chi2=1.23, df=1, p>0.05), externalizing disorders (chi2=1.25, df=1, 
p>0.05) or other disorders (chi2=0.84, df=1, p>0.05). 
Clinical experience and professional background 
Under both conditions of disclosure and non-disclosure of DAWBA diagnoses, the total agreements 
between DAWBA expert and clinician diagnoses was independent of the degree of professional 
expertise (table 3) as well as of specialist group (psychiatrists vs. psychologists) (table 4) for any 
disorder, internalizing disorders, externalizing disorders, and other disorders.  
 10
Discussion 
The present study addressed the agreement of diagnoses based on the DAWBA vs. the ordinary 
clinical process of diagnostic assessment. Furthermore, the impact of DAWBA on clinical decision-
making in a clinical sample from a large child and adolescent mental health service was analyzed. 
To the best of our knowledge, so far, no published study has tested the effects on SDI measures 
on clinical decision-making by use of a randomized design like the parallel study by Ford et al. 
(submitted) and the present study. Due to well-known limitations, neither DAWBA expert-rated 
diagnoses nor clinicians’ diagnoses were taken as the “gold standard”. In consequence, the 
present study did not focus on the validation of DAWBA diagnoses in a strict sense but, rather, 
addressed the clinical utility and practicality of the DAWBA. In comparison to the parallel study by 
Ford et al. (submitted) there were a few minor differences in the design. First, the sample in the UK 
study was younger than in the present study and did not contain adolescent patients. Secondly, 
Ford et al. (submitted) disclosed the computer diagnosis of the DAWBA to clinicians, whereas this 
study disclosed the diagnosis generated by expert clinical raters. Thirdly, the UK study used the 
clinical options of “definite”, “possible”, and “no” diagnosis and matched these options to 
probabilities of diagnoses against data from the British Child Mental Health Survey [22, 23]. Given 
the lack of similar data from Switzerland, the present study used only the two categories of 
“definite” and “no” by collapsing the “possible” option into the “definite” option.  
 
In addition, it should be noted that the pattern of diagnoses provided by the participating clinicians 
in the present study very much reflects the composition of a referred sample rather than a 
community sample. There was a large proportion of externalizing disorders, with hyperkinetic 
disorder being substantially commoner than internalizing disorders and developmental disorders. 
This is strikingly different from the findings from a representative community study that had been 
performed some fifteen years previously in the same area, showing that anxiety disorders were 
commonest, followed by ADHD and a rather small proportion of oppositional defiant disorders [28]. 
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In this clinic sample, the inter-rater reliability of the DAWBA expert diagnoses was very satisfactory 
in predicting the presence of any diagnosis as well as for the presence of an internalizing, 
externalizing or other diagnosis. This is in line with  previous findings on the reliability of the 
DAWBA in community samples [6, 7, 15],. In the present study DAWBA expert raters and 
independent clinical raters did not differ significantly in their total frequency of diagnoses, though 
clinical raters typically made just one diagnosis and DAWBA raters were more likely to make 
multiple diagnoses. A tendency for clinicians to focus on the presenting problem and miss 
comorbidity has been noted previously [13]. Diagnostic agreements were fair to moderate for any 
disorder as well as for internalizing and externalizing disorders. Furthermore, diagnostic 
agreements were good for some diagnoses from the category of other disorders such as selective 
mutism and eating disorders.  
 
The disclosure of DAWBA information before clinical decision making had an impact only on the 
total agreement regarding internalizing disorders, which was significantly increased compared to 
the condition when DAWBA diagnoses were not disclosed. As a consequence, after disclosure 
Cohen’s kappa for internalizing disorders rose to a moderate degree. More specifically, the kappa 
coefficients of PTSD and depression increased considerably. In contrast to internalizing disorders, 
we did not detect a significant difference between the disclosure and non-disclosure condition 
regarding the total diagnostic agreement on externalizing disorders and other disorders. 
Furthermore, across all diagnostic categories, the rate of positive agreements was equal or higher 
when DAWBA information was disclosed. This result suggests that access to DAWBA information 
may be more likely to prompt clinicians to add an extra diagnosis than it is to prompt them to 
withdraw a diagnosis that they would otherwise have made.  
 
The moderate agreements for internalizing disorders, externalizing disorders and other disorders 
are in line with previous studies comparing SDI and clinical judgments, finding similar kappa values 
of 0.29 for externalizing and 0.28 for internalizing disorders [26]. In agreement with these findings, 
an initial study by R. Goodman and colleagues [13] analyzed 39 clinical cases from Manchester 
and London and compared DAWBA findings and diagnoses from case notes. This study found 
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similar convergence between the two types of diagnoses (kappa values of 0.48 for internalizing 
disorders, 0.40 for disruptive behavior disorders and 0.64 for hyperkinetic disorders). The 
agreement between computer diagnosis and clinician diagnosis in the parallel UK study by Ford et 
al. (submitted) was all in all comparable to the present study under both the disclosure and the 
non-disclosure condition.   
 
However, two subsequent studies found even higher rates of agreement between DAWBA expert 
diagnoses and clinician diagnoses [1, 24]. Using the Arabic version of the DAWBA, Alyahri and R. 
Goodman [1] found kappa values of 0.63 for internalizing disorders and of 0.69 for externalising 
disorders. Finally, Mullick and R. Goodman [24] found higher convergence of DABWA and clinical 
diagnoses in a clinical sample of Bangladesh (any disorder kappa = 0.81, internalizing disorder kappa 
= 0.94, hyperkinetic disorder kappa = 0.63 and disruptive behaviour disorder kappa = 0.64). Perhaps 
the lower agreement in the present study is attributable to larger teams and more varied trainings than 
in the two low-income countries that were previously studied.   
 
In a previous study that was performed in the same clinic as the present analyses, the inter-rater 
reliability of ICD-10 diagnoses was clearly superior in senior child and adolescent psychiatrists as 
compared to junior child and adolescent psychiatrists and clinical psychologists [27]. However, in 
the present study no significant differences were found in comparing diagnoses made by 
experienced vs. non-experienced clinicians or psychiatrists vs. psychologists in their agreement 
with DAWBA diagnoses. The difference between the present and the previous study was 
unexpected and would warrant further exploration. 
 
The present study showed that the total agreement regarding internalizing disorders increased 
significantly after the DAWBA diagnosis had been disclosed. This was not true for externalizing 
disorders. The diagnoses of affective and anxiety disorders are strongly influenced by clinicians’ 
assumptions and beliefs [25], potentially leading to missed or inappropriate treatment. Knowing that 
access to DAWBA information increases the diagnosis of emotional disorders does not in itself 
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prove that the resultant diagnosis is more accurate or leads to more effective treatment – though 
previous studies of standardized diagnostic interviews suggests that this is a realistic hope [17]. 
 
Finally, without detailed knowledge of the exact processes it is difficult to explain why the impact of 
DAWBA information on clinical decision-making was so limited. Firstly, practitioners may have 
been right in overruling some DAWBA diagnoses by applying the ICD-10 criteria that symptoms 
may have been better explained by another diagnosis. Secondly, some diagnoses by the clinicians 
may have been based on information that was not available in the DAWBA, e.g. direct observations 
and psychological testing. Thirdly, some of the previously mentioned barriers in clinicians regarding 
the use of SDI may have also affected the present findings [16, 21]. Thus, future research should 
be aiming for a more detailed analysis of clinical decision making under ordinary mental health 
service conditions. 
 
Limitations 
There was no strict control of the procedure of diagnostic decision making and it was not 
practicable to test the reliability of diagnoses within clinical teams. It was also not realistic to try to 
decide which source was right when the DAWBA and clinical diagnoses differed. While comparable 
information was collected by all DAWBA assessments, the length and focus of the clinical 
assessments was too varied to permit valid consensus diagnoses. Furthermore, the sample sizes 
for some of the more specific disorders were relatively small.   
 
Conclusions 
The present study used the DAWBA under normal clinic conditions in a large group of patients 
assessed by a heterogeneous group of clinicians. Like other SDI, the DAWBA diagnoses show 
only fair to moderate agreement with the diagnoses made by clinicians. This may partly reflect the 
well-recognized low reliability of clinical diagnoses based on unstructured interviews. The use of 
the DAWBA resulted in increased diagnosis of emotional disorders, and it could potentially also 
allow clinicians to avoid the trap of focusing excessively on the presenting problem, thereby 
missing significant comorbidity. The primary purposes of including the DAWBA or any other SDI in 
 14
a clinical assessment is to make psychiatric diagnoses more accurate. Future studies should 
explore the causes of discrepancies between SDI and clinical diagnoses and investigate why 
clinicians’ diagnoses are influenced only to such a small extent by the disclosure of SDI data. 
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Table 1: Frequencies of ICD-10 diagnoses by DAWBA expert raters 
and by clinicians in the sample without DAWBA information (N = 
126) 
 Diagnoses 
given by 
DAWBA 
raters 
Diagnoses 
given by 
clinicians 
Statistical 
Test a, b
 
 N = 126 N =126  
Any disorder 98 (77.8%) 97 (77.0%) 0.00 n.s. 
 One diagnosis 47 (37.3%) 71 (56.3%) 9.45** 
 Two diagnoses 36 (28.8%) 19 (15.1%) 6.24* 
 Three or more diagnoses 15 (11.9%) 7 (5.6%) n.s. 
Internalizing disorders 45 (35.7%) 26 (20.6%) 7.90* 
  Anxiety disorders 30 (23.8%) 19 (15.1%) 3.45 n.s. 
   Separation Anxiety disorders 5 (4.0%) 1 (0.8%) n.s. 
   Specific phobias 14 (11.1%) 2 (1.6%) ** 
   Social phobias 7 (5.6%) 4 (3.2%) n.s. 
   PTSD 1 (0.8%) 1 (0.8%) n.s. 
   OCD 4 (3.2%) 4 (3.2%) n.s. 
   Generalized anxiety disorders 7 (5.6) 7 (5.6%) n.s. 
  Affective disorders 20 (15.9%) 7 (5.6%) * 
   Depression 13 (10.3%) 7 (5.6%) n.s. 
Externalizing disorders 50 (39.7%) 47 (37.3%) 0.11 n.s. 
   Hyperactivity disorders 43(34.1%) 42 (33.3%) 0.00 n.s. 
   ODD 29 (23.0%) 7 (5.6%) 15.75*** 
   CD 7 (5.6%) 6 (4.8%) n.s. 
Other disorders 22 (17.5%) 43 (34.1%) 12.25*** 
   PDD/Autism 8 (6.3%) 8 (6.3%) n.s. 
   Eating disorder 3 (2.4%) 6 (4.8%) n.s. 
   Selective mutism 1 (0.8%) 2 (1.6%) n.s. 
   Other non specified disorder 10 (7.9%) 29 (23.0%) 10.45** 
Note: PTSD = posttraumatic stress disorders, OCD = obsessive-
compulsive disorders, ODD = oppositional defiant disorders, CD = conduct 
disorders, a = McNemar chi2, b = Binomial distribution (If fewer than 25 
cases change values binominal distribution was used instead of chi2 
statistics), c = Pearson chi2 ,* = significance (two sided), p <.05, ** = 
significance (two sided), p <.01, *** = significance (two sided), p <.001
Table 2: Level of agreement between DAWBA expert diagnoses and clinical diagnoses according to whether DAWBA was or was not disclosed to clinicians 
 DAWBA diagnosis disclosed to clinicians (n = 144)  DAWBA diagnosis not disclosed to clinicians 
(n = 126)  
 DAWBA + 
Clinician  
DAWBA 
only 
Clinician 
only 
Total 
agreement κ 
 DAWBA + 
Clinician  
DAWBA 
only 
Clinician 
only 
Total 
agreement κ 
Any disorders 103 (71.5%) 20 (13.9%) 14 (9.7%) 110 (76.4%) 0.15 n.s.  82 (65.1%) 16 (12.7%) 15 (11.9%) 95 (75.4%) 0.30** 
Internalizing disorders 24 (16.7%) 30 (20.8%) 3 (2.1%) 111 (77.1%) 0.46***  15 (11.9%) 30 (23.8%) 11 (8.7%) 85 (67.5%) 0.22* 
  Anxiety disorders 17 (11.8%) 22 (15.3%) 5 (3.5%) 117 (81.3%) 0.45***  10 (7.9%) 20 (15.9%) 9 (7.1%) 97 (77.0%) 0.27** 
   Separation anxiety disorder 2 (1.4%) 7 (4.9%) 1 (0.7%) 136 (94.4%) 0.31***  0 (0.0%) 5 (4.0%) 1 (0.8%) 120 (95.2%) -0.01 n.s. 
   Specific phobias 2 (1.4%) 10 (6.9%) 2 (1.4%) 132 (91.7%) 0.22**  1 (0.8%) 13 (10.3%) 1 (0.8%) 112 (88.9%) 0.10 n.s. 
   Social phobias 2 (1.4%) 6 (4.2%) 6 (4.2%) 132 (91.7%) 0.21*  2 (1.6%) 5 (4.1%) 2 (1.6%) 119 (94.4%) 0.34*** 
   PTSD 1 (0.7%) 0 (0.0%) 0 (0.0%) 144 (100.0%) 1.00***  0 (0.0%) 1 (0.8%) 1 (0.8%) 124 (98.4%) -0.01 n.s. 
   OCD 2 (1.4%) 3 (2.1%) 0 (0.0%) 141 (98%) 0.56***  2 (1.6%) 2 (1.6%) 2 (1.6%) 122 (96.8%) 0.48*** 
   Generalized anxiety disorders 3 (2.1%) 7 (4.9%) 3 (2.1%) 134 (93.1%) 0.34***  1 (0.7%) 6 (4.8%) 6 (4.8%) 114 (90.5%) 0.09 n.s. 
  Affective disorders 8 (5.6%) 15 (11.4%) 4 (2.8%) 125 (86.8%) 0.39***  3 (2.4%) 4 (3.2%) 17 (13.5%) 105 (83.3%) 0.15* 
   Depression 7 (4.9%) 9 (6.3%) 3 (2.1%) 132 (91.7%) 0.50***  3 (2.4%) 9 (7.1%) 3 (2.4%) 114 (90.5%) 0.29** 
Externalizing disorders  43 (29.9%) 23 (16.0%) 31 (21.5%) 90 (62.5%) 0.25**  30 (23.8%) 20 (15.9%) 17 (13.5%) 89 (70.6%) 0.38*** 
   Hyperactivity disorders 35 (24.3%) 23 (16.0%) 16 (11.1%) 105 (72.9%) 0.43***  26 (20.6%) 17 (13.5%) 16 (12.7%) 93 (73.8%) 0.41*** 
   ODD 15 (10.4%) 36 (25.0%) 2 (1.4%) 106 (73.6%) 0.32**  4 (3.2%) 25 (19.8%) 3 (2.4%) 98 (77.8%) 0.15* 
   CD 4 (2.8%) 12 (8.3%) 6 (4.2%) 126 (87.5%) 0.24**  2 (1.6%) 5 (4.0% 4 (3.2%) 117 (92.9%) 0.27** 
Other disorders 24 (16.7%) 15 (10.4) 26 (18.1%) 103 (71.5%) 0.34***  16 (12.7%) 7 (5.6%) 29 (23.0%) 90 (71.4%) 0.30*** 
   PDD/Autism 8 (5.6%) 3 (2.1%) 8 (5.6%) 133 (92.4%) 0.55***  4 (3.2%) 4 (3.2%) 4 (3.2%) 118 (93.7%) 0.47*** 
   Selective mutism 1 (0.7%) 1 (0.7%) 0 (0.0%) 143 (99.3%) 0.66***  1 (0.8%) 1 (0.8%) 0 (0.0%) 125 (99.2%) 0.66*** 
   Eating disorders 2 (1.4%) 2 (1.4%) 2 (1.4%) 140 (97.2%) 0.49***  3 (2.4%) 0 (0.0%) 3 (2.4%) 123 (97.6%) 0.66*** 
Note: PTSD = posttraumatic stress disorders, OCD = obsessive-compulsive disorders, ODD = oppositional defiant disorders, CD = conduct disorders, κ = Cohen’s 
kappa, * = significance (two sided), p <.05, ** = significance (two sided), p <.01, *** = significance (two sided), p <.001. 
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 Table 3: Frequencies of total agreements of more experienced and less experienced clinicians with and without 
DAWBA information 
 Frequency of total diagnostic agreement by 
clinicians with DAWBA information 
(n = 144) 
 Frequency of total diagnostic agreement by 
clinicians without DAWBA information 
(n = 126) 
 More 
experienced 
clinicians 
 (n = 64) 
Less 
experienced 
clinicians 
 (n = 80) 
chi2  More 
experienced 
clinicians 
 (n = 53) 
Less 
experienced 
clinicians 
 (n = 73) 
chi2
Any disorders  51 (79.7%) 59 (73.8% 0.70 n.s.  40 (75.5% 55 (75.3%) 0.00 n.s. 
Internalizing disorders 51 (79.7%) 60 (75.0%) 0.44 n.s.  36 (67.9%) 49 (67.1%) 0.09 n.s. 
Externalizing disorders 40 (62.5%) 50 (62.5%) 0.00 n.s.  40 (75.5%) 49 (67.1%) 1.03 n.s. 
Other disorders 50 (78.1%) 53 (66.3%) 2.46 n.s.  39 (73.6%) 51 (69.9%) 0.21 n.s. 
Note: * = significance (two sided), p <.05, ** = significance (two sided), p <.01, *** = significance (two sided), p <.001. 
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 Table 4: Frequencies of total agreements of psychiatrists and psychologists with and without DAWBA information 
 Frequency of total diagnostic agreement by 
clinicians with DAWBA information 
(n = 144) 
 Frequency of total diagnostic agreement by 
clinicians without DAWBA information 
(n = 126) 
 Psychiatrists 
(n = 49) 
Psychologists 
(n = 95) 
chi2  Psychiatrists 
(n = 45) 
Psychologists 
(n = 81) 
chi2
Any disorders  37 (75.5%) 73 (76.8%) 0.03 n.s.  31 (68.9%) 64 (79.0%) 1.60 n.s. 
Internalizing disorders 39 (79.6%) 72 (75.8%) 0.27 n.s.  34 (75.6%) 5 (61.7%) 2.10 n.s. 
Externalizing disorders 32 (65.3%) 58 (61.1%) 0.25 n.s.  31 (68.9%) 58 (71.6%) 0.10 n.s. 
Other disorders 32 (65.3%) 71 (74.7%) 1.41 n.s.  32 (71.1%) 58 (71.6%) 0.03 n.s. 
Note: * = significance (two sided), p <.05, ** = significance (two sided), p <.01, *** = significance (two sided), p <.001. 
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Figure 1: Flow chart describing progress of participants trough randomized trial 
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Online Appendix: CONSORT checklist of items to include when reporting a randomized trial 
Paper section and topic Item Descriptor Reported Reported on 
page number 
Title and abstract 1 How participants were allocated to interventions (e.g., random allocation", "randomized", or "randomly assigned"). 1 & 2 
Introduction    
  Background 2 Scientific background and explanation of rationale. 3 
Methods    
  Participants 3 Eligibility criteria for participants and the settings and locations where the data were collected. 5 
  Interventions 4 Precise details of the interventions intended for each group and how and when they were actually administered. 4 
  Objectives 5 Specific objectives and hypotheses. 4 
  Outcomes 6 Clearly defined primary and secondary outcome measures and, when applicable, any methods used to enhance the quality of 
measurements (e.g., multiple observations, training of assessors). 
4/5 
  Sample size 7 How sample size was determined and, when applicable, explanation of any interim analyses and stopping rules. 5 
  Randomization    
    Sequence generation 8 Method used to generate the random allocation sequence, including details of any restriction (e.g., blocking, stratification). 6 
    Allocation concealment 9 Method used to implement the random allocation sequence (e.g., numbered containers or central telephone), clarifying whether 
the sequence was concealed until interventions were assigned. 
6 
    Implementation 10 Who generated the allocation sequence, who enrolled participants, and who assigned participants to their groups. 6 
  Blinding (masking) 11 Whether or not participants, those administering the interventions, and those assessing the outcomes were blinded to group 
assignment. If done, how the success of blinding was evaluated. 
6 
  Statistical methods 12 Statistical methods used to compare groups for primary outcome(s); Methods for additional analyses, such as subgroup analyses 
and adjusted analyses. 
7 
Results    
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  Participant flow 13 Flow of participants through each stage (a diagram is strongly recommended). Specifically, for each group report the numbers of 
participants randomly assigned, receiving intended treatment, completing the study protocol, and analyzed for the primary 
outcome. Describe protocol deviations from study as planned, together with reasons. 
Figure 1 
  Recruitment 14 Dates defining the periods of recruitment and follow-up. 5 
  Baseline data 15 Baseline demographic and clinical characteristics of each group. 4, table 2 
  Numbers analyzed 16 Number of participants (denominator) in each group included in each analysis and 
whether the analysis was by intention-to-treat". State the results in absolute numbers 
when feasible (e.g., 10/20, not 50%). 
6 
  Outcomes and estimations 17 For each primary and secondary outcome, a summary of results for each group, 
and the estimated effect size and its precision (e.g., 95% confidence interval). 
8/9 
  Ancillary analyses 18 Address multiplicity by reporting any other analyses performed, including subgroup analyses and adjusted analyses, indicating 
those pre-specified and those exploratory. 
9 
  Adverse events 19 All important adverse events or side effects in each intervention group. 6 
Discussion    
  Interpretation 20 Interpretation of the results, taking into account study hypotheses, sources of potential bias or imprecision and the dangers 
associated with multiplicity of analyses and outcomes. 
7/10 
  Generalizability 21 Generalizability (external validity) of the trial findings. 12 
  Overall evidence 22 General interpretation of the results in the context of current evidence. 10/11 
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